Takashi Fukuda

Corporate Officer/Principal presso SANKYO CO., LTD.

Producer Manufacturing

Health Technology

Profilo

Takashi Fukuda has held the following positions in his career: Director & Senior Managing Director at ARK Resource Co. Ltd.
and Executive Officer & Deputy GM-Products at Sankyo Co., Ltd.

Posizioni attive di Takashi Fukuda

Società	Posizione	Inizio
SANKYO CO., LTD.	Corporate Officer/Principal	29/10/2010
ARK Resource Co. Ltd. ARK Resource Co. Ltd. BiotechnologyHealth Technology ARK Resource Co. Ltd. is a Japanese company that specializes in the manufacturing of monoclonal and polyclonal antibodies, fertilized eggs in mouse/rats, and culture used for reproductive engineering. ARK Resource Co. was founded in 1966 and is based in Kumamoto, Japan, with headquarters located at 383-2 Nakahara-cho, Nishi-ku, Kumamoto-shi, Kumamoto. The company offers a wide range of services from units to g units, including the supply of mouse monoclonal antibodies by ascelonus method and culture method. The company also provides a quick diagnostic genetic modified animal breeding colony by the service introduction pcr method, performing homo / hetero / wild type screening (geno typing). The company can identify specific disease bacteria in biological samples and culture cells.	Director/Board Member	-

Tutte le posizioni attive di Takashi Fukuda

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Takashi Fukuda

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SANKYO CO., LTD.	Producer Manufacturing

Aziende private	1
ARK Resource Co. Ltd. ARK Resource Co. Ltd. BiotechnologyHealth Technology ARK Resource Co. Ltd. is a Japanese company that specializes in the manufacturing of monoclonal and polyclonal antibodies, fertilized eggs in mouse/rats, and culture used for reproductive engineering. ARK Resource Co. was founded in 1966 and is based in Kumamoto, Japan, with headquarters located at 383-2 Nakahara-cho, Nishi-ku, Kumamoto-shi, Kumamoto. The company offers a wide range of services from units to g units, including the supply of mouse monoclonal antibodies by ascelonus method and culture method. The company also provides a quick diagnostic genetic modified animal breeding colony by the service introduction pcr method, performing homo / hetero / wild type screening (geno typing). The company can identify specific disease bacteria in biological samples and culture cells.	Health Technology